Reclaim the Tumor Microenvironment via “Immunoforming”
Quadrant BioSciences Develops Saliva Tests to Detect Brain Diseases and Injuries
Another "CRISPR Calamity"? U.K. Team Reports CRISPR-Induced Gene Rearrangements
New Findings Call the Precision of CRISPR-Cas9 Gene Editing into Question
Blood Protein Linked to Mental Disorders
Consciousness-Aiding Protein Produced by Cells Deep in the Brainstem
Cannabinoid-Based Drugs Seek New High, Part I
Developers Anticipate Additional Approvals after FDA Nod for Epidiolex
Andrea Toell Ph.D.
Andrea Toell, Ph.D., is a product manager at Lonza Walkersville. This article is, in part, a summary of the latest advancements in gene editing as discussed at the IBC’s Genome Editing Applications Meeting 2015, which was recently attended by Dr Toell.
More GEN Content From This Contributor
- Feature Articles: A CRISPR Look at Genome Editing
- Tutorials: Genome Editing: An Inside Job
- Feature Articles: Unlocking the Potential of CRISPR-Based Gene Editing